Company intelligence / Profile preview
Abdi İbrahim
Istanbul, Istanbul, Turkeyabdiibrahim.com.tr ↗
- Ownership
- Private
- Employees
- ~5500
- Development stage
- Commercial
01
Overview
Abdi İbrahim is the leader of Turkey's pharmaceutical industry since 2002, with a large product portfolio of nearly 250 brands and more than 500 products. The company has manufacturing facilities for chemical products, biotechnology, hormones, sterile ophthalmology, sterile inhalation products, and is developing facilities for sterile injectable and oncology products[2][4].
- Therapeutic areas
- OncologyImmunology
- Modalities
- Small moleculesbiotechnology productsbiosimilarsmonoclonal antibodies (mAbs)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
OM Pharma (28.5% stake)mAbxience (technology transfer agreement)Aronpharma (distribution rights for Berroxin brand)INOLIVA (90% share acquisition)
Beyond the preview
Go deeper on Abdi İbrahim.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Abdi İbrahim.